Latest News

FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer
FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer

June 11th 2025

Polling Data Show Updates in Treatment of mNSCLC with EGFR Mutations
Polling Data Show Updates in Treatment of mNSCLC with EGFR Mutations

June 10th 2025

More News